fam-trastuzumab deruxtecan-nxki for injection. FDA Approved

FDA approved Anti-Cancer medicine fam-trastuzumab deruxtecan-nxki for injection. FDA-Approved is available upon request. To get best retail price of  fam-trastuzumab deruxtecan-nxki for injection. FDA-Approved in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email info@pharmatourismhub.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical Oncologist.
Category: .

fam-trastuzumab deruxtecan-nxki for injection, for intravenous use Initial U.S. Approval: 2019

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting.
This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
For injection: 100 mg lyophilized powder in a single-dose vial

HOW TO MAKE AN ENQUIRY FOR fam-trastuzumab deruxtecan-nxki for injection?

FDA approved Anti-Cancer medicine fam-trastuzumab deruxtecan-nxki for injection is available upon request. Get best retail price of fam-trastuzumab deruxtecan-nxki for injection from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@pharmatourismhub.com. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Occupational therapists .

Trastuzumab deruxtecan also known as fam-trastuzumab deruxtecan and sold under the brand name Enhertu, is a medication used for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting.

Trastuzumab deruxtecan is an antibody-drug conjugate that includes a human epidermal growth factor receptor 2 (HER2)-directed antibody trastuzumab and a topoisomerase I inhibitor conjugate deruxtecan (a derivative of exatecan). It was approved for use in the United States in December 2019.

HOW AND WHERE TO BUY fam-trastuzumab deruxtecan-nxki INJECTION?

You can order fam-trastuzumab deruxtecan-nxki injection direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery. To get best retail price/cost of fam-trastuzumab deruxtecan-nxki injection for injection in India, Call 8750295029 or Email urgent@pharmatourismhub.comFDA approved drugs of Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.


Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.